Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Reports in Pharmaceutical Sciences
  4. Articles

  5. Green Peas Protein Hydrolyzed by Bromelain in Simple Procedure to Improve Kidney Function in Cisplatin-induced Rats
  6. Scopus by Title (Ref)

Journal of Reports in Pharmaceutical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Publication Malpractice StatementReviewer and AE Registration FormSupportContact Us
APCAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Peptides with biological and technofunctional properties produced by bromelain hydrolysis of proteins from different sources: A review

- Tacias-Pascacio V.G. , et al.

2. Recent Advances in In Vitro and In Vivo Studies of Antioxidant, ACE-Inhibitory and Anti-Inflammatory Peptides from Legume Protein Hydrolysates

- Tawalbeh D. , et al.

3. Sub-chronic toxicity study of green peas protein hydrolysate in rats

- Hidayat M. , et al.

4. Bromelain a potential bioactive compound: A comprehensive overview from a pharmacological perspective

- Chakraborty A.J. , et al.

HomeInstructionsAPCAnnouncement of New Publisher

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.